In HCC, KLF4 acts as a transcription factor, directly activating the expression of CD9, CD81, EpCAM, and CD133/Prominin-1 (81, 118) to suppress HCC cell proliferation through the EGFR and JNK signaling pathways. Here, EGFR is linked to hepatocellular carcinoma.